C

ICU Medical, Inc. ICUI

$168.33 $7.494.66% NASDAQ
Recommendation
Dividend Power Score
Day's Range
$160.67$168.62
Latest Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
Access our Premium Ratings
Get Access

ICUI Rating

Reward
Risk

ICUI Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

ICUI Company Overview

ICU Medical, Inc. is a U.S.-based medical technology company that develops, manufactures, and sells medical devices used in infusion therapy, intravenous (IV) systems, oncology treatment delivery, and critical care applications. The company operates within the broader healthcare equipment and supplies industry, serving hospitals, alternate site care providers, ambulatory clinics, and pharmaceutical customers. ICU Medical’s portfolio includes infusion pumps, IV consumables, needlefree connectors, vascular access products, and oncology preparation systems designed to improve patient safety and reduce infection risks.

The company’s primary revenue drivers are its infusion systems and consumable products, with recurring revenue supported by the ongoing use of disposable medical supplies in healthcare settings. ICU Medical expanded significantly through acquisitions, most notably the acquisition of Smiths Medical from Smiths Group in 2022, which materially broadened its infusion device and vascular access portfolio. Founded in 1984 by George A. Lopez, the company initially focused on needlefree IV connectors and evolved into a diversified infusion therapy and critical care device manufacturer with global operations.

Data compiled by narrative technology. May contain errors.
Sector

ICUI Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

ICUI Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

ICUI Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

ICUI Price History

Loading...
52-Week Range69% of range
Current
$168.33
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return

ICUI Valuation

Market Cap
Market Cap Rank
#4,134
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

ICUI Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

ICUI Corporate Info

Phone Number
949 366 2183
Address
951 Calle Amanecer
San Clemente, CA 92673
Country
Year Founded

ICUI Filings

Filing Date
Thursday, August 6, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 2 and 6 (est)

ICUI Headlines